Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin
Tóm tắt
Từ khóa
Tài liệu tham khảo
Reynolds, 1983, Why does epilepsy become intractable? Prevention of chronic epilepsy, Lancet, 2, 952, 10.1016/S0140-6736(83)90462-2
Patsalos, 1994, New antiepileptic drugs-a review of their current status and clinical potential, Cns Drugs, 2, 40, 10.2165/00023210-199402010-00005
Bauer, 1995, Efficacy and tolerability of tiagabine-results of an add-on study in patients with refractory partial seizures, J Epilepsy, 8, 83, 10.1016/0896-6974(94)00015-R
Richens, 1995, Adjunctive treatment of partial seizures with tiagabine: A placebo controlled trial, Epilepsy Res, 21, 37, 10.1016/0920-1211(95)00006-V
Fink-Jensen, 1992, The γ-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats, Eur J Pharmacol, 220, 197, 10.1016/0014-2999(92)90748-S
Borden, 1994, Tiagabine, SK-&-F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1, Eur J Pharmacol, 269, 219, 10.1016/0922-4106(94)90089-2
Braestrup, 1990, (R)-N-(4,4-bis(3-methyl-2thienyl)but-3-en-1-yl)nipecotic acid (tiagabine) binds with high affinity to the brain GABA uptake carrier, J Neurochem, 54, 639, 10.1111/j.1471-4159.1990.tb01919.x
Nielsen, 1991, Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor, Eur J Pharmacol, 196, 257, 10.1016/0014-2999(91)90438-V
Smith, 1995, The γ-aminobutyric-acid uptake inhibitor, tiagabine, is anticonvulsant in 2 animal-models of reflex epilepsy, Eur J Pharmacol, 273, 259, 10.1016/0014-2999(94)00696-5
Cheung, 1992, An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium-channels, Epilepsy Res, 13, 107, 10.1016/0920-1211(92)90065-2
Grove, 1981, Increased γ-aminobutyric acid (GABA), homocarnisine and β-alanine in the cerebrospinal fluid of patients treated with γ-vinyl GABA (4-amino-hex-5-enoic acid), Life Sci, 28, 2431, 10.1016/0024-3205(81)90511-7
Jung, 1977, γ-vinyl GABA (4-amino-hex-5-enoic acid) a new irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice, J Neurochem, 29, 797, 10.1111/j.1471-4159.1977.tb10721.x
Honmou, 1995, Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neurons in-vitro, Epilepsy Res, 20, 193, 10.1016/0920-1211(94)00076-9
Honmou, 1995, The anticonvulsant gabapentin enhances promoted release of GABA in hippocampus-a field potential analysis, Brain Res, 692, 273, 10.1016/0006-8993(95)00634-3
Petroff, 1995, Gabapentin increases brain γ-aminobutyric-acid levels in patients with epilepsy, Ann Neurol, 38, 295
Löscher, 1988, Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations, Epilepsy Res, 2, 145, 10.1016/0920-1211(88)90054-X
Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic press, 1986.
Racine, 1972, Modification of seizure activity by electrical stimulation: II. Motor seizure, Electroencephal Clin Neurophysiol, 32, 281, 10.1016/0013-4694(72)90177-0
Litchfield, 1949, A simplified method of evaluating dose-effect experiments, J Pharmacol Exp Ther, 96, 99
Leiderman, 1994, Gabapentin as add-on therapy for refractory partial epilepsy-results of 5 placebo-controlled trials, Epilepsia, 35, S74, 10.1111/j.1528-1157.1994.tb05974.x
Reynolds, 1992, Gamma-vinyl GABA (vigabatrin)-clinical-experience in adult and adolescent patients with intractable epilepsy, Epilepsia, 33, S30
Smith, 1993, Outcomes of add-on treatment with lamotrigine in partial epilepsy, Epilepsia, 34, 312, 10.1111/j.1528-1157.1993.tb02417.x
Bartoszyk GD, Meyerson N, Reimann W, Satzinger G, Von Hodenberg A. Gabapentin. In: Meldrum BS, Porter RJ, editors. New Anticonvulsant Drugs. London: Libbey, 1986:147–163.
Smith, 1993, Excitatory amino-acid antagonists, lamotrigine and BW-1003C87 as anticonvulsants in the genetically epilepsy-prone rat, Epilepsy Res, 15, 101, 10.1016/0920-1211(93)90091-K
Vergnes M, Marescaux C, Pathophysiological mechanisms underlying genetic absence epilepsy in rats. In: Malafosse A, Genton P, Hirsch E, Marescaux C, Broglin D, Bernasconi R, editors. Idiopathic generalized epilepsies: clinical, experimental and genetic aspects. London: John Libbey and Company Ltd, 1994:151–168.
Lamb, 1985, Effect of lamotrigine and some known anticonvulsant drugs on visually-evoked after-discharge in the conscious rat, Br J Pharm, 86, 765
Buchanan, 1995, Lamotrigine in the treatment of absence seizures, Acta Neurol Scand, 92, 348, 10.1111/j.1600-0404.1995.tb00141.x
Löscher, 1989, Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model, Eur J Pharmacol, 163, 1, 10.1016/0014-2999(89)90389-0
Foot M, Wallace J. Gabapentin. In: Pisani F, Perucca E, Avanzani G, Richens A, editors. New Antiepileptic Drugs. Elsevier Science Publishers, 1991:109–114.
Otsuki, 1995, Anticonvulsant effects of lamotrigine, a novel antiepileptic drug on amygdaloid and hippocarnpal kindled seizures in rats, Jpn J Neuropsychopharmacol, 17, 35
Schwark, 1985, Comparison of the anticonvulsant effects of two novel GABA uptake inhibitors and diazepam in amygdaloid kindled rats, Naunyn-Scmeideberg's Arch Pharmacol, 329, 367, 10.1007/BF00496369
Albertson, 1980, Anticonvulsant drugs and their antagonism of kindled amygdaloid seizures in rats, Neuropharmacology, 19, 643, 10.1016/0028-3908(80)90038-6
Ikegaki, 1994, Production of specific antibodies against GABA-transporter subtypes (GAT1, GAT2, GAT3) and their application to immunocytochemistry, Brain Res, 26, 47, 10.1016/0169-328X(94)90072-8
Hill, 1993, Localisation of 3H-gabapentin to a novel site in rat brain: autoradiographic studies, Eur J Pharmacol, 244, 303, 10.1016/0922-4106(93)90156-4